Battle for control: Canadian investor Prem Watsa gives IIFL promoters cause to worry
Canadian investor Prem Watsa’s open offer to public shareholders of IIFL to buy out their 26 per cent has become a reason to worry for its promoters
Nishant Vasudevan
Underweight on India as stock valuations are quite high: Joanne Goh, DBS Bank
India’s stock valuations have already priced in most of the positives, said Joanne Goh, senior equity strategist — group research, DBS Bank.
Participatory notes: A sensitive topic for govt, SEBI and investors
P-notes are offshore derivative instruments used by foreign investors who are interested in betting on Indian securities but not keen on registering with SEBI
Greek Impact: Indian markets may see selloff soon, fund managers sound caution
Indian stocks erased losses and ended higher, bucking the weak trend in other Asian markets, led by a rally in top pharma stocks.
Small mutual funds step up fight over cap on upfront fees
The bone of contention is the recent Amfi move to put a cap on upfront fees mutual funds pay distributors.
Heard on the Street: IDFC MF’s star picks, and discussion on GIFT
Investors are worried that a new fund manager may shuffle the portfolio which could lead to the fund’s exit from some of these stocks.
MFs may exclude SIPs from upfront fee restrictions
Mutual funds may take a U-turn on the recent decision to limit upfront commissions to distributors, a move that was aimed to check misselling.
Funds may not allow investors to use bonus units to save tax
Investors will not be able to avail of the tax benefit known as bonus stripping —a practice that has been frowned upon by the capital markets regulator.
Dalal Street nervous? Minimum Alternate Tax worries to continue on inflows from US, UK
Equity assets under custody of foreign portfolio investors (FPIs) from the US alone was Rs 6.75 lakh crore as on March 30.
Pharma stocks fall after BofA-ML downgrade
Pharma cos including Sun Pharma, Lupin, Cadila Healthcare and Cipla weakened on Thursday after BofA-ML's downgrade.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon
